138 related articles for article (PubMed ID: 16226951)
41. [Autocrine stimulation of receptor-tyrosine kinases (RTK) in human tumor cell lines in vitro: therapeutic implications].
Gaumann A; Groot M; Drexler HC; Breier G
Verh Dtsch Ges Pathol; 2003; 87():232-9. PubMed ID: 16888917
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of pancreatic cancer cell proliferation by propranolol occurs through apoptosis induction: the study of beta-adrenoceptor antagonist's anticancer effect in pancreatic cancer cell.
Zhang D; Ma Q; Shen S; Hu H
Pancreas; 2009 Jan; 38(1):94-100. PubMed ID: 19106745
[TBL] [Abstract][Full Text] [Related]
43. An anti-K-ras ribozyme suppresses oncogene expression and cell growth of human pancreatic cancer.
Sakuma T; Kijima H; Nishi M; Abe Y; Yamazaki H; Mine T; Nakamura M; Ueyama Y
Tokai J Exp Clin Med; 2004 Jun; 29(2):35-42. PubMed ID: 15473338
[TBL] [Abstract][Full Text] [Related]
44. Expression of receptor for advanced glycation end products (RAGE) and MMP-9 in human pancreatic cancer cells.
Takada M; Hirata K; Ajiki T; Suzuki Y; Kuroda Y
Hepatogastroenterology; 2004; 51(58):928-30. PubMed ID: 15239215
[TBL] [Abstract][Full Text] [Related]
45. Epiregulin is Up-regulated in pancreatic cancer and stimulates pancreatic cancer cell growth.
Zhu Z; Kleeff J; Friess H; Wang L; Zimmermann A; Yarden Y; Büchler MW; Korc M
Biochem Biophys Res Commun; 2000 Jul; 273(3):1019-24. PubMed ID: 10891365
[TBL] [Abstract][Full Text] [Related]
46. Protease-activated receptor-2 expression and the role of trypsin in cell proliferation in human pancreatic cancers.
Ohta T; Shimizu K; Yi S; Takamura H; Amaya K; Kitagawa H; Kayahara M; Ninomiya I; Fushida S; Fujimura T; Nishimura G; Miwa K
Int J Oncol; 2003 Jul; 23(1):61-6. PubMed ID: 12792776
[TBL] [Abstract][Full Text] [Related]
47. Expression of YPEL1 in pancreatic cancer cell lines and tissues.
Abiatari I; Kiladze M; Kerkadze V; Friess H; Kleeff J
Georgian Med News; 2009 Oct; (175):60-2. PubMed ID: 19893129
[TBL] [Abstract][Full Text] [Related]
48. Endogenous tumor necrosis factor promotes resistance to cellular stresses by inducing the metallothionein-1A gene.
Hadama T; Kinoshita M; Kobayashi D; Tsuji N; Watanabe N
Anticancer Res; 2002; 22(6C):4059-63. PubMed ID: 12553033
[TBL] [Abstract][Full Text] [Related]
49. Decreased tissue levels of cyclophilin A, a cyclosporine a target and phospho-ERK1/2 in simvastatin patients with abdominal aortic aneurysm.
Piechota-Polanczyk A; Demyanets S; Nykonenko O; Huk I; Mittlboeck M; Domenig CM; Neumayer C; Wojta J; Nanobachvili J; Klinger M
Eur J Vasc Endovasc Surg; 2013 Jun; 45(6):682-8. PubMed ID: 23558220
[TBL] [Abstract][Full Text] [Related]
50. Different capabilities of morphological pattern formation and its association with the expression of differentiation markers in a xenograft model of human pancreatic cancer cell lines.
Neureiter D; Zopf S; Dimmler A; Stintzing S; Hahn EG; Kirchner T; Herold C; Ocker M
Pancreatology; 2005; 5(4-5):387-97. PubMed ID: 15980667
[TBL] [Abstract][Full Text] [Related]
51. Cyclophilin A: potential functions and therapeutic target for human cancer.
Obchoei S; Wongkhan S; Wongkham C; Li M; Yao Q; Chen C
Med Sci Monit; 2009 Nov; 15(11):RA221-32. PubMed ID: 19865066
[TBL] [Abstract][Full Text] [Related]
52. CD147 is a signaling receptor for cyclophilin B.
Yurchenko V; O'Connor M; Dai WW; Guo H; Toole B; Sherry B; Bukrinsky M
Biochem Biophys Res Commun; 2001 Nov; 288(4):786-8. PubMed ID: 11688976
[TBL] [Abstract][Full Text] [Related]
53. Suppressive effects of exogenous regucalcin on the proliferation of human pancreatic cancer MIA PaCa-2 cells in vitro.
Yamaguchi M; Murata T
Int J Mol Med; 2015 Jun; 35(6):1773-8. PubMed ID: 25847529
[TBL] [Abstract][Full Text] [Related]
54. Ribosomal protein P2: a potential molecular target for antisense therapy of human malignancies.
Gardner-Thorpe J; Ito H; Ashley SW; Whang EE
Anticancer Res; 2003; 23(6C):4549-60. PubMed ID: 14981896
[TBL] [Abstract][Full Text] [Related]
55. Enhanced levels of Hsulf-1 interfere with heparin-binding growth factor signaling in pancreatic cancer.
Li J; Kleeff J; Abiatari I; Kayed H; Giese NA; Felix K; Giese T; Büchler MW; Friess H
Mol Cancer; 2005 Apr; 4(1):14. PubMed ID: 15817123
[TBL] [Abstract][Full Text] [Related]
56. Inhibitory effect of resveratrol on the expression of the VEGF gene and proliferation in renal cancer cells.
Yang R; Zhang H; Zhu L
Mol Med Rep; 2011; 4(5):981-3. PubMed ID: 21687947
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of pancreatic carcinoma cell growth in vitro by DPC4 gene transfection.
Shen W; Tao GQ; Li DC; Zhu XG; Bai X; Cai B
World J Gastroenterol; 2008 Oct; 14(40):6254-60. PubMed ID: 18985820
[TBL] [Abstract][Full Text] [Related]
58. [Responses of pancreatic cancer cells to stimulations by nerve growth factor and the role of Trk-A expression].
Diao DM; Song YC; Hou N; Xu HF; Wang JG; Dang CX
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):296-300. PubMed ID: 22445970
[TBL] [Abstract][Full Text] [Related]
59. The ABCC4 gene is a promising target for pancreatic cancer therapy.
Zhang Z; Wang J; Shen B; Peng C; Zheng M
Gene; 2012 Jan; 491(2):194-9. PubMed ID: 21989485
[TBL] [Abstract][Full Text] [Related]
60. Expression of cyclophilin A and CD147 during skin aging.
Li J; Xie H; Yi M; Peng L; Lei D; Chen X; Jian D
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 36(3):203-11. PubMed ID: 21464540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
